Blog

Drug Safety in Pregnancy & Lactation | Breastfeeding Drug Safety | Pharmacovigilance | BPharm Notes

During pregnancy, a large part of the body is affected by the physiological and anatomical changes that start in early pregnancy. Many of these changes significantly affect the pharmacokinetic (absorption, distribution, metabolism, and excretion) and pharmacodynamic properties of different drugs […]

Continue Reading

Drug Safety in Geriatric Population | Drug safety evaluation special population | Pharmacovigilance

Elderly patients are the main users of drugs and they difer from younger patients. They are a heterogeneous population that cannot be defned only by age but should rather be stratifed based on their frailty. The elderly have distinctive pharmacokinetic […]

Continue Reading

Diploma in Pharmacy Exit Examination Regulations 2022 Announced by PCI

Diploma in Pharmacy Exit Examination Regulations Objective The objective of the Diploma in Pharmacy Exit Examination (DPEE) is to ensure that a candidate applying for registration as pharmacist with the State Pharmacy Council has undergone pharmacy education and a comprehensive […]

Continue Reading

Differences in Indian & Global Pharmacovigilance Requirement | Comparison of USA, India, European Pharmacovigilance System

Pharmacovigilance in India Indian pharmaceutical industries are estimated to account for about 3.5% in value of the international pharmaceutical industry. By 2020, it is expected to grow to US$55 billion and US$100 billion by 2025, thus evolving as the sixth […]

Continue Reading

CIOMS | CIOMS Working Group | History of CIOMS | Pharmacovigilance notes unit 5 | BPharm 8 semester

CIOMS: The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. CIOMS represents a substantial proportion of the biomedical scientific community through its member organizations, which include […]

Continue Reading

Expedited reporting | ICH Guidelines for Pharmacovigilance | MCQ | Pharmacovigilance Notes & Lecture for BPharm 8th Semester

STANDARDS FOR EXPEDITED REPORTING A. What Should be Reported? 1. Single Cases of Serious, Unexpected ADRs All adverse drug reactions (ADRs) that are both serious and unexpected are subject to expedited reporting. This applies to reports from spontaneous sources and […]

Continue Reading

ICH Guidelines for Pharmacovigilance | Organization and objectives of ICH | Pharmacovigilance Notes for BPharma 8 semester

Introduction: • ICH is the “International Conference on Harmonization” of technical requirements for the registration of pharmaceuticals for human use. • To assure safety, quality and efficacy of medicines, the members of ICH who include members from drug regulatory authorities […]

Continue Reading

Developed By Connect Globes